Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12871900 | 0.72 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL12871888 | 0.72 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL1191489 | 0.72 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL14444992 | 0.69 | — | — | |
| SCHEMBL16422616 | 0.66 | — | — | |
| SCHEMBL11776824 | 0.66 | — | — | |
| SCHEMBL11073756 | 0.66 | — | — | |
| SCHEMBL6922892 | 0.65 | ALDH1A1 (0.46) | TSHRCASP1ALDH1A1 | |
| SCHEMBL1878800 | 0.65 | ALDH1A1 (0.46) | TSHRCASP1ALDH1A1 | |
| SCHEMBL1878801 | 0.65 | ALDH1A1 (0.46) | TSHRCASP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7691844-B2 | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-7365062-B2 | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20070135409-A1 | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2007-06-14 | — | — | US | disclosed |
| US-20070117790-A1 | 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135409-A1 | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists | AVPR1B, AVPR2, AVPR1A | TSHR 101/4885CASP1 3724/4885ALDH1A1 1346/4885 |
| US-20070117790-A1 | 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure | AVPR1B, AVPR2, BDKRB1 | TSHR 114/4885CASP1 3920/4885ALDH1A1 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.